References
- Nome RV, Småstuen MC, Fosså SD, et al. Thyroid hypofunction in aging testicular cancer survivors. Acta Oncol. 2021;60(11):1452–1458.
- Skakkebaek NE, Rajpert-De Meyts E, Main KM. Testicular dysgenesis syndrome: an increasingly common developmental disorder with environmental aspects. Hum Reprod. 2001;16(5):972–978.
- Sharpe RM. Hormones and testis development and the possible adverse effects of environmental chemicals. Toxicol Lett. 2001;120(1–3):221–232.
- Fung C, Sesso HD, Williams AM, et al. Multi-Institutional assessment of adverse health outcomes among North American testicular cancer survivors after modern cisplatin-based chemotherapy. J Clin Oncol. 2017;35(11):1211–1222.
- Kerns SL, Fung C, Monahan PO, for the Platinum Study Group, et al. Cumulative burden of morbidity among testicular cancer survivors after standard cisplatin-based chemotherapy: a multi-institutional study. J Clin Oncol. 2018;36(15):1505–1512.
- Udovcic M, Pena RH, Patham B, et al. Hypothyroidism and the heart. Methodist Debakey Cardiovasc J. 2017;13(2):55–59.
- Meikle AW. The interrelationships between thyroid dysfunction and hypogonadism in men and boys. Thyroid. 2004;14(Suppl 1):S17–S25.